NCT00367315View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,684

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

February 29, 2004

Conditions
Knee Osteoarthritis
Interventions
DRUG

Lumiracoxib

Trial Locations (2)

Unknown

Novartis, Nuremberg

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY